COPD Imaging: New Tools to Tackle an Old Problem?

References

• Santos S, Peinado VI, Ramirez J, Melgosa T, Roca J, Rodriguez-Roisin R, Barber‡ JA. Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD. Euro Respir J 2002; 19:632–638.
   PubMed Web of Science ®Google Scholar
• Wells JM, Washko GR, Han MK, Abbas N, Nath H, Marnary AJ, Regan E, Bailey WC, Martinez FJ, Westfall E, Beaty TH, Curran-Everett D, Curtis JL, Hokanson JE, Lynch DA, Make BJ, Crapo JD, Silverman EK, Bowler RP, Dransfield MT, COPD Gene Investigators: ECLIPSE Study Investigators. Pulmonary arterial enlargement and acute exacerbations of COPD. New Engl J Med 2012; 367:913–921.
   PubMed Web of Science ®Google Scholar
• Hizawa N, Makita H, Nasuhara Y, Betsuyaku T, Itoh Y, Nagai K, Hasegawa M, Nishimura M. Beta2-adrenergic receptor genetic polymorphisms and short-term bronchodilator responses in patients with COPD. Chest 2007; 132:1485–1492.
   PubMed Web of Science ®Google Scholar
• Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R, Miller B, Lomas DA, Agusti A, Macnee W, Calverley P, Rennard S, Wouters EF, Wedzicha JA, Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010; 363:1128–1138.
   PubMed Web of Science ®Google Scholar
• Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A, Weinmann G, Wood DE, National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume ≠reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003; 348:2059–2073.
   PubMed Web of Science ®Google Scholar
• Sciurba FC, Ernst A, Herth FJ, Strange C, Criner CJ, Marquette CH, Kovitz KL, Chiacchierini RP, Goldin J, McLennan G, VENT Study Research Group. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med 2010; 363:1233–1244.
   PubMed Web of Science ®Google Scholar
• Gompelmann D, Eberhardt R, Michaud G, Ernst A, Herth FJ. Predicting atelectasis by assessment of collateral ventilation prior to endobronchial lung volume reduction: a feasibility study. Respiration 2010; 80:419–425.
   PubMed Web of Science ®Google Scholar
• Rennard SI, Calverley PM, Goehring UM, Bredenbrˆker D, Martinez FJ. Reduction of exacerbations by the PDE4 inhibitor roflumilast—the importance of defining different subsets of patients with COPD. Respir Res 2011; 12:18.
   PubMed Web of Science ®Google Scholar
• Cardoso PF, Snell GI, Hopkins P, Sybrecht GW, Starnatis G, Ng AW, Eng P. Clinical application of airway bypass with paclitaxel-eluting stents: early results. J Thor Cardiovasc Surg 2007; 134:974–981.
   PubMed Web of Science ®Google Scholar
• Snell GI, Hopkins P, Westall G, Holsworth L, Carle A, Williams TJ. A feasibility and safety study of bronchoscopic thermal vapor ablation: a novel emphysema therapy. Ann Thor Surg 2009; 88:1993–1998.
   PubMed Web of Science ®Google Scholar
• Reilly J, Washko G, Pinto-Plata V, Velez E, Kenney L, Berger R, Celli B. Biological lung volume reduction: a new bronchoscopic therapy for advanced emphysema. Chest 2007; 131:1108–1113.
   PubMed Web of Science ®Google Scholar
• Wan IY, Toma TP, Geddes DM, Bronchoscopic lung volume reduction for end-stage emphysema: report on the first 98 patients. Chest 2006;129:518–526.
   PubMed Web of Science ®Google Scholar
• Hoesein FAAM, De Jong P, Lammers JWJ, Contribution of CT quantified emphysema, air trapping and airway wall thickness on pulmonary function in male smokers with and without COPD. J COPD 2014;11:503–509.
   PubMedGoogle Scholar
• Xia Y, Guan Y, Fan L, Dynamic contrast enhanced magnetic resonance perfusion imaging in high risk smokers and smoking-related COPD: Correlations with pulmonary function tests and quantitative computed tomography. J Chron Obstruct Pulmon Dis 2014;11:510–520.
   Web of Science ®Google Scholar
• Muller NL, Staples CA, Miller RR, Abboud RT. ìDensity maskî. An objective method to quantitate emphysema using computed tomography. Chest 1988; 94:782–787.
   PubMed Web of Science ®Google Scholar
• Nakano Y, Muro S, Sakai H, Hirai T, Chin K, Tsukino M, Nishimura K, Itoh H, ParÈ PD, Hogg JC, Mishima M. Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am J Respir Crit Care Med 2000; 162:1102–1108.
   PubMed Web of Science ®Google Scholar
• Eda S, Kubo K, Fujimoto K, Matsuzawa Y, Sekiguchi M, Sakai F. The relations between expiratory chest CT using helical CT and pulmonary function tests in emphysema. Am J Respir Crit Care Med 1997; 155:1290–1204.
   PubMed Web of Science ®Google Scholar
• Patel BD, Coxson HO, Pillai SG, Agusti AG, Calverley PM, Donner CF, Make BJ, Muller NL, Rennard SI, Vestbo J, Wouters EF, Hiorns MP, Nakano Y, Camp PG, Nasute Fauerbach PV, Screaton NJ, Campbell EJ, Anderson WH, Pare PD, Levy RD, Lake SL, Silverman EK, Lomas DA, International COPD Genetics Network. Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 178:500–505.
   PubMed Web of Science ®Google Scholar
• Grydeland TB, Thorsen E, Dirksen A, Jensen R, Coxson HO, Pillai SG, Sharma S, Eide GE, Gulsvik A, Bakke PS. Quantitative CT measures of emphysema and airway wall thickness are related to D(L)CO. Respir Med 2011;105:343–351.
   PubMed Web of Science ®Google Scholar
• Lee YK, Oh YM, Lee JH, Kim EK, Lee JH, Kim N, Seo JB, Lee SD, KOLD Study Group. Quantitative assessment of emphysema, air trapping, and airway thickening on computed tomography. Lung 2008; 186:157–165.
   PubMed Web of Science ®Google Scholar
• Alford SK, van Beek EJ, McLennan G, Hoffman EA. Heterogeneity of pulmonary perfusion as a mechanistic image-based phenotype in emphysema susceptible smokers. Proc Natl Acad Sci USA 2010; 107:7485–7490.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Surveillance Summaries, August 2, 2002. MMWR 2002:51(No. SS–6). Epidemiology Program Office, Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services, Atlanta, GA 30333.
   Google Scholar
• Sorheim IC, Johannessen A, Gulsvik A, Gender differences in COPD: are women more susceptible to smoking effects than men? Thorax 2010; 65:480–485.
   PubMed Web of Science ®Google Scholar
• Prescott E, Bjerg AM, Andersen PK, Lange P, Vestbo J. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Euro Respir J 1997; 10:822–827.
   PubMed Web of Science ®Google Scholar
• Dransfield MT, Davis JJ, Gerald LB, Bailey WC. Racial and gender differences in susceptibility to tobacco smoke among patients with chronic obstructive pulmonary disease. Respir Med 2006; 100:1110–1116.
   PubMed Web of Science ®Google Scholar
• Foreman MG, Zhang L, Murphy J, Hansel NN, Make B, Hokanson JE, Washko G, Regan EA, Crapo JD, Silverman EK, DeMeo DL, COPDGene Investigators. Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPDGene Study. AmJRespirCrit Care Med 2011; 184:414–420.
   PubMed Web of Science ®Google Scholar